Inovio Pharmaceuticals Inc. Stock Advances 21.1%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. sailed 21.1% to $1.09 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,729.16 and Dow Jones Industrial Average falling 0.2% to 53,732.41.

This was the stock's fifth consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 63.4% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.7% to $260.35, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. remained unchanged.

Trading volume totaled 12.1 million, compared to the 50-day average of 3.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 14, 2026 16:33 ET (20:33 GMT)